Lotus Eye Hospital and Institute Limited

NSEI:LOTUSEYE Stok Raporu

Piyasa değeri: ₹1.3b

Lotus Eye Hospital and Institute Yönetim

Yönetim kriter kontrolleri 4/4

Lotus Eye Hospital and Institute CEO'su Kuttapalayam Ramalingam, Aug2020 tarihinde atandı, in görev süresi 4.25 yıldır. şirketin hisselerinin 1.43% doğrudan sahiptir ve bu hisselerin değeri ₹ 19.07M dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 4.2 yıl ve 3.8 yıldır.

Anahtar bilgiler

Kuttapalayam Ramalingam

İcra Kurulu Başkanı

₹1.2m

Toplam tazminat

CEO maaş yüzdesin/a
CEO görev süresi4.3yrs
CEO sahipliği1.4%
Yönetim ortalama görev süresi4.2yrs
Yönetim Kurulu ortalama görev süresi3.8yrs

Son yönetim güncellemeleri

Recent updates

Optimistic Investors Push Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) Shares Up 25% But Growth Is Lacking

Aug 21
Optimistic Investors Push Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) Shares Up 25% But Growth Is Lacking

Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) Price Is Out Of Tune With Earnings

Jan 24
Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) Price Is Out Of Tune With Earnings

Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50

Sep 08
Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50

We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease

Jul 15
We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease

Here's Why Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Has Caught The Eye Of Investors

Apr 07
Here's Why Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Has Caught The Eye Of Investors

We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease

Oct 08
We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease

Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50

Sep 02
Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50

If EPS Growth Is Important To You, Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Presents An Opportunity

Jun 17
If EPS Growth Is Important To You, Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Presents An Opportunity

MD & Whole Time Director Sangeetha Sundaramoorthy Just Bought 2.8% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)

Mar 11
MD & Whole Time Director Sangeetha Sundaramoorthy Just Bought 2.8% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)

Chief Executive Officer K. Ramalingam Just Bought 122% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)

Dec 30
Chief Executive Officer K. Ramalingam Just Bought 122% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)

Insider Buying: The Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) MD & Whole Time Director Just Bought 2.8% More Shares

Nov 20
Insider Buying: The Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) MD & Whole Time Director Just Bought 2.8% More Shares

The Chief Executive Officer of Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE), K. Ramalingam, Just Bought 17% More Shares

Sep 21
The Chief Executive Officer of Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE), K. Ramalingam, Just Bought 17% More Shares

Why Investors Shouldn't Be Surprised By Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) P/E

Aug 27
Why Investors Shouldn't Be Surprised By Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) P/E

Should You Take Comfort From Insider Transactions At Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)?

Aug 03
Should You Take Comfort From Insider Transactions At Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)?

Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) P/E Isn't Throwing Up Surprises

Jul 06
Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) P/E Isn't Throwing Up Surprises

CEO

Kuttapalayam Ramalingam (74 yo)

4.3yrs

Görev süresi

₹1,200,000

Tazminat

Dr. Kuttapalayam Songappan Ramalingam, M.D., serves as an Executive Director at Lotus Eye Hospital and Institute Limited since February 10, 2021. Dr. Ramalingam serves as Chief Executive Officer at Lotus E...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Kuttapalayam Ramalingam
CEO & Executive Director4.3yrs₹1.20m1.43%
₹ 19.1m
Ramanujam Reghunathan
Chief Financial Officer2.5yrs₹1.70mVeri yok
Mohanmenon Menon
Company Secretary & Compliance Officer2.8yrs₹1.08mVeri yok
Sangeetha Sundaramoorthy
MD & Director4.2yrs₹3.09m18.84%
₹ 250.4m
Rajkumar Sundaramoorthy
Vice President of Administration6.5yrsVeri yok0%
₹ 0

4.2yrs

Ortalama Görev Süresi

67yo

Ortalama Yaş

Deneyimli Yönetim: LOTUSEYE 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 4.2 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Kuttapalayam Ramalingam
CEO & Executive Director3.8yrs₹1.20m1.43%
₹ 19.1m
Sangeetha Sundaramoorthy
MD & Director5yrs₹3.09m18.84%
₹ 250.4m
Rajkumar Sundaramoorthy
Vice President of Administration4.8yrsVeri yok0%
₹ 0
Kavetha Sundaramoorthy
Chairman of the Board8.5yrs₹150.00k18.78%
₹ 249.6m
Sengodagounder Natesan
Independent Director3.8yrs₹200.00kVeri yok
Gopalakrishnan Veeramani
Independent Non-Executive Director1.9yrs₹200.00kVeri yok
Perumalsamy Mahendran
Independent Non-Executive Director1.8yrs₹175.00kVeri yok

3.8yrs

Ortalama Görev Süresi

61yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: LOTUSEYE 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.8 yıldır).